Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug. your-feed-science, Drugs (Pharmaceuticals), Clinical Trials, Aduhelm (Drug), Alzheimer's Disease, Labeling and Labels (Product), Brain, Elderly, Deaths (Fatalities), Biogen Inc, Food and Drug Administration, JAMA Neurology (Journal), RBC Capital Markets, Research